Belton, TX, United States of America

Darrell Watson

This inventor holds 2 USPTO granted patents, plus 4 CIPO patents. Top assignee: Research Corporation Technologies, Inc.. Active years: 1995-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Darrell Watson. Retrieved from https://idiyas.com/inventor/darrell-watson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 1995-1997

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Darrell Watson

Introduction

Darrell Watson is an accomplished inventor based in Belton, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticonvulsant compounds. With a total of 2 patents to his name, Watson's work is focused on addressing critical health issues.

Latest Patents

Watson's latest patents include an amino acid derivative anticonvulsant. This invention relates to compounds that exhibit central nervous system (CNS) activity, which are useful in the treatment of epilepsy and other CNS disorders. The compounds of this invention have a specific general formula and include pharmaceutically acceptable salts thereof.

Career Highlights

Watson is currently employed at Research Corporation Technologies, Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has the potential to significantly impact the treatment of neurological disorders.

Collaborations

Watson collaborates with various professionals in his field, including his coworker Harold L Kohn, to enhance the development of his inventions.

Conclusion

Darrell Watson's contributions to the field of anticonvulsants highlight his dedication to improving healthcare through innovation. His work exemplifies the importance of research and development in addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…